Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Mesothelioma
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2009
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 10 Sep 2009 Last checked against ClinicalTrials.gov record.
- 10 Sep 2009 Status changed from recruiting to discontinued as reported by CLinicalTrials.gov
- 09 Apr 2008 The expected completion date for this trial is now 1 Dec 2011 according to ClinicalTrials.gov.